Levels of nitric oxide metabolites, adiponectin and endothelin are associated with SNPs of the adiponectin and endothelin genes

Gumanova,Nadezhda   G.; Klimushina,Marina   V.; Smetnev,Stepan   A.; Kiseleva,Anna   V.; Skirko,Olga   P.; Meshkov,Alexey   N.; Shanoyan,Artem   S.; Kots,Alexander   Y.; Metelskaya,Victoria   A.

doi:10.3892/br.2019.1238

Levels of nitric oxide metabolites, adiponectin and endothelin are associated with SNPs of the adiponectin and endothelin genes

Authors:
- Nadezhda G. Gumanova
- Marina V. Klimushina
- Stepan A. Smetnev
- Anna V. Kiseleva
- Olga P. Skirko
- Alexey N. Meshkov
- Artem S. Shanoyan
- Alexander Y. Kots
- Victoria A. Metelskaya
View Affiliations

Affiliations: National Medical Research Center for Preventive Medicine, Ministry of Healthcare of The Russian Federation, Moscow 101990, Russia, Department of Clinical Pharmacology, Sechenov First Moscow State Medical University, Moscow 119992, Russia
Published online on: September 4, 2019 https://doi.org/10.3892/br.2019.1238
Pages: 154-164
Copyright: © Gumanova et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adiponectin, endothelin and nitric oxide (NO) are major regulators of vascular function. An imbalance of vasoactive factors contributes to the onset and progression of atherosclerosis. Various single nucleotide polymorphisms (SNPs) are considered to be risk factors for coronary heart disease. However, the molecular mechanisms of their associations with the components of endothelial dysfunction are poorly understood. In the present study, rs17366743, rs17300539, rs266729, rs182052 and rs2241766 SNPs of the adiponectin (ADIPOQ) gene and rs2070699, rs1800542 and rs1800543 SNPs of the endothelin‑1 (EDN1) gene were genotyped in 477 patients with coronary heart disease who were subjected to coronary angiography, in order to determine the presence or absence of coronary atherosclerosis. The serum levels of adiponectin, endothelin and stable metabolites of NO, (nitrate and nitrite NOx), were assayed and their associations with the SNP genotypes and coronary lesions were calculated. The results indicated that rs17366743 of the ADIPOQ gene and rs2070699 and rs1800543 of the EDN1 gene were associated with the levels of NOx in women, which in turn was associated with cardiovascular mortality. In men, rs182052 and rs266729 of the ADIPOQ gene were associated with adiponectin levels, whereas rs17366743 of the ADIPOQ gene was associated with endothelin levels. Additionally, these SNPs were indirectly associated with the prevalence of coronary lesions in men. Therefore, the tested SNPs can be considered potential risk factors that lead to imbalance of vasoactive mediators in a gender‑specific manner and contribute to the development of clinical manifestations of atherosclerosis.

View Figures

View References

1	CARDIoGRAM plus C4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, et al: Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 45:25–33. 2013.PubMed/NCBI View Article : Google Scholar
2	Vanhoutte PM, Shimokawa H, Feletou M and Tang EH: Endothelial dysfunction and vascular disease-a 30th anniversary update. Acta Physiol Oxf). 219:22–96. 2017.PubMed/NCBI View Article : Google Scholar
3	Kershaw EE and Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 89:2548–2556. 2004.PubMed/NCBI View Article : Google Scholar
4	Dastani Z, Johnson T, Kronenberg F, Nelson CP, Assimes TL and März W: CARDIoGRAM Consortium ADIPOGen Consortium and Richards JB: The shared allelic architecture of adiponectin levels and coronary artery disease. Atherosclerosis. 229:145–148. 2013.PubMed/NCBI View Article : Google Scholar
5	Chen C, Jiang J, Lü JM, Chai H, Wang X, Lin PH and Yao Q: Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 299:H193–H201. 2010.PubMed/NCBI View Article : Google Scholar
6	Wang X, Pu H, Ma C, Jiang T, Wei Q, Zhang C, Duan M, Shou X, Su L, Zhang J and Yang Y: Adiponectin abates atherosclerosis by reducing oxidative stress. Med Sci Monit. 20:1792–1800. 2014.PubMed/NCBI View Article : Google Scholar
7	Wärnberg J and Marcos A: Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 19:11–15. 2008.PubMed/NCBI View Article : Google Scholar
8	Klöting N and Blüher M: Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 15:277–287. 2014.PubMed/NCBI View Article : Google Scholar
9	Fisman EZ and Tenenbaum A: Adiponectin: A manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 13(103)2014.PubMed/NCBI View Article : Google Scholar
10	Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, et al: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 102:1296–1301. 2000.PubMed/NCBI View Article : Google Scholar
11	Brown JE, Conner AC, Digby JE, Ward KL, Ramanjaneya M, Randeva HS and Dunmore SJ: Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin. Peptides. 31:944–949. 2010.PubMed/NCBI View Article : Google Scholar
12	Tong G, Wang N, Leng J, Tong X, Shen Y, Yang J, Ye X, Zhou L and Zhou Y: Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes. Cardiovasc Diabetol. 12(67)2013.PubMed/NCBI View Article : Google Scholar
13	Chen X, Yuan Y, Gao Y, Wang Q, Xie F, Xia D, Wei Y and Xie T: Association of variant in the ADIPOQ gene and functional study for its role in atherosclerosis. Oncotarget. 8:86527–86534. 2017.PubMed/NCBI View Article : Google Scholar
14	Ahmed M and Rghigh A: Polymorphism in endothelin-1 gene: An overview. Curr Clin Pharmacol. 11:191–210. 2016.PubMed/NCBI View Article : Google Scholar
15	Liang LL, Chen L, Zhou MY, Cai MY, Cheng J, Chen Y, You SK, Chen LB, Tang ZB, Yang XL, et al: Genetic susceptibility of five tagSNPs in the endothelin-1 (EDN1) gene to coronary artery disease in a Chinese Han population. Biosci Rep. 38(BSR20171320)2018.PubMed/NCBI View Article : Google Scholar
16	Mei M, Cheng G, Sun B, Yang L, Wang H, Sun J and Zhou W: EDN1 gene variant is associated with neonatal persistent pulmonary hypertension. Sci Rep. 6(29877)2016.PubMed/NCBI View Article : Google Scholar
17	Zhang L and Sui R: Effect of SNP polymorphisms of EDN1, EDNRA, and EDNRB gene on ischemic stroke. Cell Biochem Biophys. 70:233–239. 2014.PubMed/NCBI View Article : Google Scholar
18	Gumanova NG, Gavrilova NE, Chernushevich OI, Kots AY and Metelskaya VA: Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers. 22:239–245. 2017.PubMed/NCBI View Article : Google Scholar
19	Gumanova NG, Deev AD, Kots AY and Shalnova SA: Elevated levels of serum nitrite and nitrate, NOx, are associated with increased total and cardiovascular mortality in an 8-year follow-up study. Eur J Clin Invest. 49(e13061)2019.PubMed/NCBI View Article : Google Scholar
20	Gumanova NG, Deev AD, Zhang W, Kots AY and Shalnova SA: Serum nitrite and nitrate levels, NOx, can predict cardiovascular mortality in the elderly in a 3-year follow-up study. Biofactors. 43:82–89. 2017.PubMed/NCBI View Article : Google Scholar
21	Gumanova NG, Klimushina MV and Metel'skaya VA: Optimization of single-step assay for circulating nitrite and nitrate ions (NOx) as risk factors of cardiovascular mortality. Bull Exp Biol Med. 165:284–287. 2018.PubMed/NCBI View Article : Google Scholar
22	Miranda KM, Espey MG and Wink DA: A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 5:62–71. 2001.PubMed/NCBI View Article : Google Scholar
23	Metel'skaia VA and Gumanova NG: Screening as a method for determining the serum level of nitric oxide metabolites. Klin Lab Diagn. 6:15–18. 2005.In Russian). PubMed/NCBI
24	Rodriguez S, Gaunt TR and Day IN: Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 169:505–514. 2009.PubMed/NCBI View Article : Google Scholar
25	Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, et al: Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes. 51:1247–1255. 2002.PubMed/NCBI View Article : Google Scholar
26	Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, Fox CS, O'Donnell CJ, Cupples LA and Meigs JB: Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: The Framingham Offspring Study. Diabetes. 57:3353–3359. 2008.PubMed/NCBI View Article : Google Scholar
27	Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB and Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 291:1730–1737. 2004.PubMed/NCBI View Article : Google Scholar
28	Antoniades C, Antonopoulos AS, Tousoulis D and Stefanadis C: Adiponectin: From obesity to cardiovascular disease. Obes Rev. 10:269–279. 2009.PubMed/NCBI View Article : Google Scholar
29	Luque-Ramírez M, Martínez-García MÁ, Montes-Nieto R, Fernández-Durán E, Insenser M, Alpañés M and Escobar-Morreale HF: Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum Reprod. 28:1908–1918. 2013.PubMed/NCBI View Article : Google Scholar
30	Brunner F, Brás-Silva C, Cerdeira AS and Leite-Moreira AF: Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis. Pharmacol Ther. 111:508–531. 2006.PubMed/NCBI View Article : Google Scholar
31	Kedzierski RM and Yanagisawa M: Endothelin system: The double-edged sword in health and disease. Annu Rev Pharmacol Toxicol. 41:851–876. 2001.PubMed/NCBI View Article : Google Scholar
32	Maemura K, Kurihara H, Morita T, Oh-hashi Y and Yazaki Y: Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology. 38:Suppl 1). S29–S35. 1992.PubMed/NCBI View Article : Google Scholar
33	Hattori Y, Suzuki M, Hattori S and Kasai K: Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia. 46:1543–1549. 2003.PubMed/NCBI View Article : Google Scholar
34	Maas R, Xanthakis V, Göen T, Müller J, Schwedhelm E, Böger RH and Vasan RS: Plasma nitrate and incidence of cardiovascular disease and all-cause mortality in the community: The Framingham Offspring Study. J Am Heart Assoc. 6(e006224)2017.PubMed/NCBI View Article : Google Scholar
35	Margaritis M, Antonopoulos AS, Digby J, Lee R, Reilly S, Coutinho P, Shirodaria C, Sayeed R, Petrou M, De Silva R, et al: Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation. 127:2209–2221. 2013.PubMed/NCBI View Article : Google Scholar
36	Nguyen A, Thorin-Trescases N and Thorin E: Working under pressure: Coronary arteries and the endothelin system. Am J Physiol Regul Integr Comp Physiol. 298:R1188–R1194. 2010.PubMed/NCBI View Article : Google Scholar